Publicaciones (87) Publicaciones de Puri Fortes

2024

  1. Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2

  2. Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

2023

  1. APLF and long non-coding RNA NIHCOLE promote stable DNA synapsis in non-homologous end joining

    Cell Reports, Vol. 42, Núm. 1

  2. Editorial: Long non-coding RNAs in viral infections and immunity

    Frontiers in Immunology

  3. Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals

    ACS Nano, Vol. 17, Núm. 23, pp. 23331-23346

2022

  1. DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis

    Cancers, Vol. 14, Núm. 9

  2. ISR8/IRF1-AS1 Is Relevant for IFNα and NF-κB Responses

    Frontiers in Immunology, Vol. 13

  3. U1A is a positive regulator of the expression of heterologous and cellular genes involved in cell proliferation and migration

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 831-846

2021

  1. Endogenous retroelement activation by epigenetic therapy reverses the warburg effect and elicits mitochondrial-mediated cancer cell death

    Cancer Discovery, Vol. 11, Núm. 5, pp. 1268-1285

  2. Long noncoding RNA EGOT responds to stress signals to regulate cell inflammation and growth

    Journal of Immunology, Vol. 206, Núm. 8, pp. 1932-1942

  3. Long noncoding RNA NIHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma

    Cancer Research, Vol. 81, Núm. 19, pp. 4910-4925

  4. The landscape of lncrnas in hepatocellular carcinoma: A translational perspective

    Cancers, Vol. 13, Núm. 11

2020

  1. LncRNAs in the type I interferon antiviral response

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-34

  2. Lncrnas in hcv infection and hcv-related liver disease

    International Journal of Molecular Sciences, Vol. 21, Núm. 6

  3. Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression

    Journal of Urology

  4. SMIM30, a tiny protein with a big role in liver cancer

    Journal of Hepatology

  5. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

    Journal of Clinical Investigation, Vol. 130, Núm. 4, pp. 1879-1895

2019

  1. Identification of coding and long noncoding RNAs differentially expressed in tumors and preferentially expressed in healthy tissues

    Cancer Research, Vol. 79, Núm. 20, pp. 5167-5180

  2. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

  3. The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells

    Cell Death and Disease, Vol. 10, Núm. 1